CoChat

Long‐term side‐effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study

Malone, Shawn, Perry, Gad, Segal, Roanne, Dahrouge, Simone, Crook, Juanita · 2005 · BJU International
Cited by 61

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To assess the feasibility and tolerability of intermittent androgen suppression therapy (IAS) in prostate cancer. PATIENTS AND METHODS: Patients with recurrent or metastic prostate cancer received cyclical periods of treatment with leuprolide acetate and nilutamide for 8 months, and rest periods. Cycles were repeated at progression until the treatment failed to achieve normal prostate‐specific antigen (PSA) levels. Patients were followed with PSA level, testosterone level, haemoglobin level, weight and bone mineral density evaluations. The median time to treatment failure, recovery from anaemia, or normalization of testosterone level was estimated by the Kaplan‐Meier method. RESULTS: In all, 95 patients received 245 cycles; the median duration of rest periods was 8 months and median time to treatment failure 47 months. Testosterone recovery during rest periods was documented in 117 (61%) of cycles. Anaemia was mild and reported in 33%, 44% and 67% of cycles 1, 2 and 3, respectively. Sexual function recovered during the rest periods in 47% of cycles. There was no significant overall change in body mass index at the end of the treatment period. Osteoporosis was documented in at least one site evaluated in 41 patients (37%). CONCLUSIONS: IAS has the potential to reduce side‐effects, including recovery of haemoglobin level, return of sexual function and absence of weight gain at the end of the study period.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1464-410x.2005.05676.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 61

Metadata

Authors
Malone, S., Perry, G., Segal, R., Dahrouge, S., & Crook, J.
Venue
BJU International
Publisher
Wiley
Published
2005-08-11
Volume
96
Issue
4
Pages
514-520
ISSN
  • 1464-4096 (ISSN-L)
  • 1464-410X
OpenAlex
W2074528665
Cited by
61
References
3
FWCI
5.92
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long‐term side‐effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study. https://app.cochat.ai/papers/10.1111/j.1464-410x.2005.05676.x
The paper
Malone, S., Perry, G., Segal, R., Dahrouge, S., & Crook, J. (2005). Long‐term side‐effects of intermittent androgen suppression therapy in prostate cancer: results of a phase II study. BJU International. https://doi.org/10.1111/j.1464-410x.2005.05676.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.